250 "

: Keppra 250 Mg. ?  »
|
-

PER OS

Film Coated Tablets

- Keppra is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - Keppra is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy. - Keppra is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalization in patient from 16 years of age with newly diagnosed epilepsy. - Keppra is indicated in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

132 64 31181 00

Ucb Pharma S.a., Belgium

02/2015 - 08/2015

.
, .
.
/
Levetiracetam 250 MG
Blister pvc/aluminium 100 x TABLETS 36
Blister pvc/aluminium 20 x TABLETS 36
Blister pvc/aluminium 30 x TABLETS 36
Blister pvc/aluminium 50 x TABLETS 36
Blister pvc/aluminium 60 x TABLETS 36

*

*

 

.

?

? B12?  »
 
" !
 

, .
:  »
278
"